Literature DB >> 20713867

Detecting functional impairment in older patients with cancer: is vulnerable elders survey-13 the right prescreening tool? An open question.

Cristina Falci, Antonella Brunello, Silvio Monfardini.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20713867     DOI： 10.1200/JCO.2010.30.5573

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  The importance of negative predictive value (NPV) of vulnerable elderly survey (VES 13) as a pre-screening test in older patients with cancer.

Authors:  B Castagneto; C Di Pietrantonj; I Stevani; A Anfossi; M Arzese; L Giorcelli; L Giaretto
Journal:  Med Oncol       Date:  2013-08-31       Impact factor: 3.064

2.  Basic assessment of the older cancer patient.

Authors:  Martine Extermann
Journal:  Curr Treat Options Oncol       Date:  2011-09

Review 3.  Incorporating Geriatric Medicine Providers into the Care of the Older Adult with Cancer.

Authors:  Allison Magnuson; Beverly Canin; G J van Londen; Beatrice Edwards; Pamela Bakalarski; Ira Parker
Journal:  Curr Oncol Rep       Date:  2016-11       Impact factor: 5.075

4.  Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.

Authors:  Pierre Soubeyran; Carine Bellera; Jean Goyard; Damien Heitz; Hervé Curé; Hubert Rousselot; Gilles Albrand; Véronique Servent; Olivier Saint Jean; Isabelle van Praagh; Jean-Emmanuel Kurtz; Stéphane Périn; Jean-Luc Verhaeghe; Catherine Terret; Christophe Desauw; Véronique Girre; Cécile Mertens; Simone Mathoulin-Pélissier; Muriel Rainfray
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

5.  G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy.

Authors:  Lies Pottel; Michelle Lycke; Tom Boterberg; Hans Pottel; Laurence Goethals; Fréderic Duprez; Sylvie Rottey; Yolande Lievens; Nele Van Den Noortgate; Kurt Geldhof; Véronique Buyse; Khalil Kargar-Samani; Véronique Ghekiere; Philip R Debruyne
Journal:  BMC Cancer       Date:  2015-11-09       Impact factor: 4.430

6.  Can Vulnerable Elders Survey-13 predict the impact of frailty on chemotherapy in elderly patients with gynaecological malignancies?

Authors:  Annamaria Ferrero; Michela Villa; Elisa Tripodi; Luca Fuso; Guido Menato
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

7.  Can the Vulnerable Elders-13 Survey (VES-13) scale replace the EuroSCORE scale in predicting complications in patients over 60 years of age undergoing cardiac surgery?

Authors:  Anetta Kowalczuk-Wieteska; Monika Parys; Iwona Majchrzyk; Michał Zembala; Marian Zembala
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-06-26       Impact factor: 1.426
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.